Out-of-Pocket Costs

Manufacturer cost-sharing assistance programs can save chronically ill patients hundreds to thousands of dollars annually

  • by

A recent analysis by IQVIA shows that chronically ill patients who used manufacturer cost-sharing assistance in 2019 saved hundreds to thousands of dollars on their out-of-pocket costs. IQVIA found that nearly one-third of commercially insured patients taking brand anticoagulants, diabetes or oncology medicines used manufacturer… Read More »Manufacturer cost-sharing assistance programs can save chronically ill patients hundreds to thousands of dollars annually

Commercial health plans have increased patients’ out-of-pocket costs by over 50% in some therapeutic areas

  • by

According to a recent IQVIA analysis, commercial health plans have increased patients’ average out-of-pocket costs for brand medicines by over 50% in some therapeutic areas since 2015. Notably, of the seven therapeutic areas that IQVIA analyzed, including anticoagulants, asthma/COPD, depression, diabetes, HIV, multiple sclerosis and… Read More »Commercial health plans have increased patients’ out-of-pocket costs by over 50% in some therapeutic areas

Commercial health plans’ transition from copays to coinsurance and deductibles has increased patient out-of-pocket costs for brand medicines

  • by

A decade ago, most patients paid only copays for brand medicines. But in recent years, use of deductibles and coinsurance in commercial health plans has skyrocketed. According to a recent IQVIA analysis, commercially-insured patients now pay most of their out-of-pocket spending for brand medicines in… Read More »Commercial health plans’ transition from copays to coinsurance and deductibles has increased patient out-of-pocket costs for brand medicines

Four things to know about the IQVIA “Medicine Spending and Affordability in the U.S.” report

  • by

Today, IQVIA released a new report, Medicine Spending and Affordability in the U.S., providing context on medicine price and spending trends and patient out-of-pocket costs. The report highlights an alarming trend where health plans increasingly use deductibles and coinsurance to shift more of the cost of… Read More »Four things to know about the IQVIA “Medicine Spending and Affordability in the U.S.” report

New data show commercially insured patients face increasingly high cost sharing for brand medicines

  • by

New data show deductibles and coinsurance result in high out-of-pocket spending for commercially insured patients taking brand medicines. IQVIA analyzed trends in cost sharing across seven therapy areas and found that anywhere from 44% to 95% of patients’ total out-of-pocket spending for brand medicines in… Read More »New data show commercially insured patients face increasingly high cost sharing for brand medicines